Double chin removing healthcare company Kythera Biopharmaceuticals backed by Foley Ventures, the corporate venturing unit of law firm Foley & Lardner, floats on October 10.
Kythera Biopharmaceuticals, a US-based healthcare company backed by Foley Ventures, the corporate venturing unit of law firm Foley & Lardner, has raised $70.4m in its flotation on October 10.
Kythera sold 4.4 million shares at $16 each. The company’s main product is an injectable drug for the reduction of a type of fat, which normally appears as “double chin.” The flotation price gives the company a market capitalisation of about $278m.
The flotation was advised by US-based banks JP Morgan,…
